Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Allison Keeler-Klunk
Introduction
Allison Keeler-Klunk, a distinguished inventor based in Sutton, MA, has made significant strides in the field of biotechnology. Her innovative work has resulted in one patent, showcasing her dedication to advancing research in viral vectors. The focus of her invention lies in the production of recombinant adeno-associated virus (rAAV) particles, a crucial area of study for developing gene therapies.
Latest Patents
Keeler-Klunk's patent, titled "Campaign-ready series of recombinant adeno-associated virus (rAAV) complementing plasmids," outlines compositions and methods for producing rAAV particles. This groundbreaking work is based on isolated nucleic acids and introduces a system that uses only two vectors. The method is designed for the production of multiple different single-gene viral vectors in a small-scale campaign mode, emphasizing efficiency and versatility.
Career Highlights
Allison is affiliated with the University of Massachusetts, where she continues to push the boundaries of scientific understanding. Her work has significantly contributed to the fields of virology and gene therapy, marking her as a prominent figure in her field.
Collaborations
Throughout her career, Keeler-Klunk has collaborated with notable colleagues such as Terence Flotte and Qiushi Tang. These partnerships reflect her commitment to innovation and the advancement of scientific knowledge, demonstrating the collaborative nature of research in biomedicine.
Conclusion
In summary, Allison Keeler-Klunk stands out as an influential inventor in the biotechnology arena, particularly with her patent on recombinant adeno-associated virus plasmids. Her work not only enriches the scientific community but also has the potential to impact future therapeutic developments. Through collaboration and dedication, she continues to pave the way for innovation in her field.